Renal cell carcinoma (RCC) with rhabdoid differentiation is thought to portend a poor prognosis, similar to RCC with sarcomatoid differentiation. Mayo Clinic researchers reviewed a large series of patients with grade 4 RCC to determine the differential effects of rhabdoid and sarcomatoid differentiation on patient outcome.
Mayo Clinic researchers conducted a study published in the American Journal of Gastroenterology, to determine whether patients with multifocal polysomy are more likely to manifest cholangiocarcinoma compared with patients with other chromosomal abnormalities, including unifocal polysomy and other FISH subtypes.
GenomeDx Biosciences today announced the publication of a positive validation study for the Decipher® Prostate Cancer Classifier, a new genomic test that can direct appropriate use of radiation therapy following prostate surgery.
Patient Outcome with Micropapillary Urothelial Carcinoma Following Cadical Cystectomy
- A Test in Focus
RAS/RAF Targeted Gene Panel by Next Generation Sequencing, Tumor
Triple-Negative Breast Cancer Patients Should Undergo Genetic Screening
Mayo Clinic Study Finds Chromosomal Rearrangements Help Distinguish Between Independent Primary Tumors and Metastasis
GenomeDx, Mayo Clinic to Conduct Validation Study of Decipher® Prostate Cancer Test